I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 3 studies | 20% ± 4% | |
| GABAergic neuron | 3 studies | 32% ± 10% | |
| astrocyte | 3 studies | 28% ± 12% | |
| glutamatergic neuron | 3 studies | 42% ± 12% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 3 studies | 20% ± 4% | |
| GABAergic neuron | 3 studies | 32% ± 10% | |
| astrocyte | 3 studies | 28% ± 12% | |
| glutamatergic neuron | 3 studies | 42% ± 12% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 30% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 2722.29 | 245 / 245 | 97% | 4.55 | 485 / 502 |
| thymus | 100% | 3188.44 | 653 / 653 | 96% | 3.57 | 582 / 605 |
| breast | 100% | 1480.62 | 459 / 459 | 95% | 4.03 | 1059 / 1118 |
| esophagus | 100% | 1501.70 | 1444 / 1445 | 95% | 3.18 | 173 / 183 |
| adrenal gland | 100% | 1874.68 | 258 / 258 | 93% | 3.62 | 215 / 230 |
| pancreas | 100% | 1140.39 | 328 / 328 | 93% | 2.86 | 165 / 178 |
| brain | 95% | 1196.40 | 2502 / 2642 | 96% | 3.93 | 679 / 705 |
| ovary | 100% | 1902.64 | 180 / 180 | 86% | 2.35 | 371 / 430 |
| lung | 100% | 1820.84 | 578 / 578 | 86% | 2.85 | 995 / 1155 |
| stomach | 100% | 1617.41 | 359 / 359 | 85% | 2.19 | 243 / 286 |
| kidney | 100% | 1534.72 | 89 / 89 | 84% | 2.52 | 756 / 901 |
| intestine | 100% | 1815.41 | 966 / 966 | 83% | 1.99 | 439 / 527 |
| uterus | 100% | 2549.87 | 170 / 170 | 83% | 2.10 | 382 / 459 |
| bladder | 100% | 1638.48 | 21 / 21 | 83% | 2.34 | 417 / 504 |
| skin | 99% | 808.61 | 1785 / 1809 | 72% | 1.77 | 341 / 472 |
| liver | 99% | 1001.80 | 224 / 226 | 50% | 1.02 | 205 / 406 |
| spleen | 100% | 1709.66 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.62 | 1 / 1 |
| adipose | 100% | 1272.32 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1245.67 | 1330 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 96% | 962.21 | 773 / 803 | 0% | 0 | 0 / 0 |
| heart | 96% | 1201.02 | 824 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 79% | 1.90 | 23 / 29 |
| peripheral blood | 79% | 595.26 | 735 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 67% | 1.28 | 30 / 45 |
| eye | 0% | 0 | 0 / 0 | 39% | 0.84 | 31 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005198 | Molecular function | structural molecule activity |
| Gene name | ERVK13-1 |
| Protein name | Endogenous retrovirus group K member 13-1 Env polyprotein (Envelope polyprotein) (HERV-K_16p13.3 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)] |
| Synonyms | |
| Description | FUNCTION: Retroviral envelope proteins mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution (By similarity). .; FUNCTION: SU mediates receptor recognition. .; FUNCTION: TM anchors the envelope heterodimer to the viral membrane through one transmembrane domain. The other hydrophobic domain, called fusion peptide, mediates fusion of the viral membrane with the target cell membrane (By similarity). . |
| Accessions | Q9NX77 |
